// App-Quantinova.ai

Sa1199 : Protease Inhibitors for the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP): Cochrane Collaboration Meta-Analysis of Randomized Controlled Trials

Researchers

Presenter

  • Yuhong Yuan

Principal Investigators

  • Grigorios Leontiadis

  • Paul Moayyedi

  • Alan N. Barkun

  • Frances Tse

Medical Centers

  • Medicine, Gastroenterology, McMaster University Medical Centre, Hamilton, Ontario, Canada

  • GI Division, McGill University, The Montreal General Hospital, Montreal, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

Disease

  • Pancreatitis

  • Ascending cholangitis

Biomarkers

  • Protein Tyrosine Phosphatase, Non-Receptor Type 22

Drug/Treatment

  • Ulinastatin

  • nafamostat

Outcome

  • Unknown

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved